Pharma often thwarts competition by refusing to turn over the samples a generics company needs to get a cheaper product approved. The FDA is cracking down.
Pharma often thwarts competition by refusing to turn over the samples a generics company needs to get a cheaper product approved. The FDA is cracking down.